Research & Development
8 June 2026 - Global biotechnology company Alvotech S.A. (NASDAQ:ALVO) announced on Monday that the US Food and Drug Administration (FDA) has accepted for review its Biologics License Application for ...
8 June 2026 - French healthcare company Sanofi S.A. (Euronext Paris:SAN) (Nasdaq:SNY) announced on Monday that it has received European Commission approval for subcutaneous Sarclisa (isatuximab) for m...
5 June 2026 - German pharmaceutical and life sciences company Bayer AG (ETR:BAYN) (OTC:BAYRY) on Friday reported full results from the Phase III FIND-CKD trial evaluating Kerendia (finerenone) in adul...
5 June 2026 - Biopharmaceutical company Gilead Sciences Inc (Nasdaq: GILD) and biotechnology company Lakefront Biotherapeutics NV (Euronext & Nasdaq: LKFT), formerly known as Galapagos, confirmed ...
5 June 2026 - India-based global pharmaceutical company Lupin Limited (BSE: 500257) (NSE: LUPIN) announced on Thursday that the US Food and Drug Administration (FDA) has approved its ranibizumab, Ranl...
4 June 2026 - Biopharmaceutical company Pharming Group N.V. (Euronext Amsterdam:PHARM) (NASDAQ:PHAR) announced on Thursday that the US Food and Drug Administration (FDA) has accepted the resubmitted s...